Elite Pharmaceuticals, Inc. (ELTP)
$0.29-3.33%Close
SELLCRISIS · day 6
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $312M
- Avg volume
- 640.5K
- Beta
- 0.40
- P/E (TTM)
- 5.90
- Short % float
- 0.32%
- Days to cover
- 3.7
- SI change
- +3.3%
- 1W
- -6.45%
- 1M
- -23.68%
- 3M
- -14.71%
- YTD
- -42.00%
- vs SPY 1W
- -5.08%
- vs SPY 1M
- -27.42%
- vs SPY 3M
- -17.80%
- vs SPY YTD
- -54.08%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ABTBUYAbbott LaboratoriesRECOVERYQ 16$116.64+2.19%
- ENSGBUYThe Ensign Group, Inc.RECOVERYQ 28$179.48-0.21%
- LGNDSELLLigand Pharmaceuticals IncorporatedBEARQ 14$286.29-0.38%
- MEDPBUYMedpace Holdings, Inc.BULLQ 47$620.75+1.32%
- CELG-RIBUYBristol-Myers Squibb Company CeRECOVERYQ 10$0.12+20.00%
- PACSSELLPACS Group, Inc.BEARQ 35$44.25+1.54%
- VREXBUYVarex Imaging CorporationBULLQ -5$18.51+0.11%
- DOCSSELLDoximity, Inc.RECOVERYQ 5$25.33-2.35%
- PRVASELLPrivia Health Group, Inc.CRISISQ 13$21.12-0.38%
- BLLNSELLBillionToOne, Inc.Q 0$95.03-0.25%
- SPROSELLSpero Therapeutics, Inc.RECOVERYQ 1$1.22+0.83%
- AUNABUYAuna S.A.RECOVERYQ -11$5.26+0.19%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 63
- VALUE
- 70
- GROWTH
- 64
- GARP
- 24
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC43.6%
REV YoY-19.5%
ROE74.3%
EPS YoY-
ROA40.6%
GROSS43
OP25
NET40
[VALUATION]
P/E TTM5.90
P/E FWD-
SECTOR PE22.60
INDUSTRY PE9.21
P/B3.03
P/FCF18.13
EV/EBITDA6.29
EV/EBIT7.95
PEG-
FCF YIELD5.52%
BUYBACK0.00%
RISK
INT COV115.1×
D/E5.32
ALTMAN Z7.35
CURR RATIO3.76
ND/EBITDA-0.89
BETA0.40
